LMR Partners »

C4 Therapeutics shares owned by LMR Partners

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by LMR Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $160k 20k 8.17

More positions owned by LMR Partners

Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microstrategy Cl A New Put Option (MSTR)
Ishares Tr National Mun Etf Put Option (MUB)
Vaneck Etf Trust Semiconductr Etf (SMH)
Spdr Ser Tr S&p Oilgas Exp Put Option (XOP)
NVIDIA Corporation Put Option (NVDA)
Capri Holdings SHS (CPRI)
Tripadvisor (TRIP)
Microsoft Corporation (MSFT)
BP Sponsored Adr (BP)
Advanced Micro Devices Call Option (AMD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr China Lg-cap Etf (FXI)
Stellantis SHS Put Option (STLA)

View all positions for LMR Partners

Top funds holding C4 Therapeutics

State Street Corporation
RA Capital Management
Daniel D. Thurber
Lynx1 Capital Management
Commodore Capital
Vanguard Group
Soleus Capital Management
Balyasny Asset Management
T. Rowe Price Associates
Bank of America Corporation
Silverarc Capital Management
Two Sigma Advisers
Arrowpoint Asset Management
Goldman Sachs Group
TCG Crossover Management

View all funds holding C4 Therapeutics